) has agreed to offer its popular Polycom immersive video
collaboration solutions to India-based pharmaceutical company -
Dr. Reddy's Laboratories Limited. The deal also entails Dr.
Reddy's to the Polycom RealPresence Experience (RPX) solution by
the leading video and audio conferencing equipment and related
network infrastructure provider.
Polycom's video conferencing technology will bridge the gap
between the employees of Dr. Reddy's Hyderabad and New Jersey
offices through direct communication. Moreover, availability of
RealPresence applications on iOS and Android platforms will
enable employees in the two parts of the world to attend
Polycom's RPX technology will help the co-workers of both the
corporate offices to view drug and generic samples and get
feedbacks without delay. Such technology implemented by Dr.
Reddy's Laboratories will not only save time for the employees
but also reduce traveling expenses.
At present, Polycom is undergoing a transition from
hardware-centric to cloud and software-centric business model.
The company has formed a consortium of open video exchange cloud
with 14 leading telecom service providers across the world.
Notable among them are
Verizon Communication Inc.
). This consortium will deliver business-to-business (B2B) video
conferencing through the cloud network.
In the recently concluded first quarter, Polycom outperformed,
with both the top and the bottom line beating the respective
Zacks Consensus Estimate. Despite a 2% year-over-year decline in
the overall revenues, the American region reported a 3% increase
The corporate video conferencing business is mainly dominated by
). Thus, we believe that winning such strategic deals will help
Polycom to register revenue growth as well as to retain its
market position, going forward.
Currently, Polycom carries a Zacks Rank #2 (Buy).
CISCO SYSTEMS (CSCO): Free Stock Analysis
POLYCOM INC (PLCM): Free Stock Analysis
AT&T INC (T): Free Stock Analysis Report
VERIZON COMM (VZ): Free Stock Analysis Report
To read this article on Zacks.com click here.